`Filed: March 18, 2016
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`AMNEAL PHARMACEUTICALS LLC, PAR PHARMACEUTICAL, INC., and
`WOCKHARDT BIO AG
`
`Petitioners,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.
`
`Patent Owner
`
`________________
`
`Case IPR2015-005471
`Patent 7,765,107
`________________
`
`
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER’S REQUEST FOR ORAL ARGUMENT
`PURSUANT TO 37 C.F.R. § 42.70
`
`
`1 Case IPR2015-01820 has been joined with this proceeding.
`
`
`
`
`
`
`
`
`Patent Owner Request for Oral Argument Case IPR2015-00547
`Patent 7,765,107
`
`Patent Owner, Jazz Pharmaceuticals, Inc. hereby requests that oral argument
`
`be held before the Patent Trial and Appeal Board (the “Board”) pursuant to
`
`37 C.F.R. § 42.70 and the Board’s July 28, 2015 Scheduling Order (Paper 26). As
`
`set forth in its Order, the Board has currently scheduled the oral hearing for
`
`April 19, 2016. This request encompasses each of the issues addressed in
`
`Petitioners’ Petition (as applicable after institution) and Reply, Patent Owner’s
`
`Response, and all exhibits thereto, including declarations and depositions. The
`
`specific issues Patent Owner wishes to address are set forth below, without waiver
`
`or prejudice.
`
`ISSUES TO BE ARGUED
`
`1. Whether Petitioners have met their burden of proving that the ACA
`
`Materials (Exs. 1003-1006) qualify as prior art.
`
`2.
`
`Claim construction – The proper construction of the following terms:
`
`a.
`
`b.
`
`c.
`
`“determining with the computer processor . . . patterns of
`
`potential prescription abuse . . . from periodic reports generated
`
`only by the central database”;
`
`“wherein said [prescription] request data contain information
`
`identifying the patient”; and
`
`“wherein said [prescription] request data contain information
`
`identifying . . . credentials of the medical doctor”.
`
`
`
`
`
`Patent Owner Request for Oral Argument Case IPR2015-00547
`Patent 7,765,107
`
`
`3. Whether Petitioners’ Reply contains improper reply evidence and
`
`arguments.
`
`4. Whether Petitioners have met their burden of proving the challenged
`
`claims of U.S. Patent No. 7,765,107 (Ex. 1001) unpatentable as
`
`obvious over the ACA Materials (Exs. 1003-1006).
`
`Jazz’s and Petitioners’ Motion(s) to Exclude Evidence, if any.
`
`Responses to any issues raised by Petitioners in their Request for Oral
`
`Argument or at the oral hearing.
`
`Any other issues that the Board deems necessary for issuing a final
`
`5.
`
`6.
`
`7.
`
`written decision.
`
`Patent Owner respectfully requests that the Board provide audio-visual
`
`equipment to display demonstrative exhibits, including a projector and screen.
`
`Finally, Jazz notes that the patent-at-issue in this IPR is related to patents
`
`currently being review in IPR2015-00545, -546, -548, -551, and -554. As these
`
`proceedings have certain overlapping issues, Jazz respectfully requests a combined
`
`hearing for all six proceedings, with 90 minutes of oral argument time per side in
`
`the combined oral hearing. The Board has already scheduled April 19, 2016 as the
`
`hearing date for all six IPRs. Further, as the parties agreed, and subject to the
`
`Board’s approval, Jazz respectfully requests that it be able to prepare and file one
`
`set of demonstratives for all six proceedings. The parties propose that the
`
`
`
`
`2
`
`
`
`Patent Owner Request for Oral Argument Case IPR2015-00547
`Patent 7,765,107
`
`
`demonstratives cite: (1) IPR2015-00548’s pleadings and exhibits for issues
`
`common across all six IPRs; and (2) the other proceedings’ pleadings and exhibits
`
`only when necessary to address issues specific to those proceedings.
`
`
`
`Date: March 18, 2016
`
`
`
`
`
`
` Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito (Reg. No. 38,100)
` Eric C. Stops (Reg. No. 51,163)
` Evangeline Shih (Reg. No. 50,170)
` Frank C. Calvosa (Reg. No. 69,064)
`QUINN EMANUEL URQUHART &
`SULLIVAN, LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`General Tel: (212) 849-7000
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`ericstops@quinnmemanuel.com
`evangelineshih@quinnemanuel.com
`frankcalvosa@quinnemanuel.com
`
`John V. Biernacki
`Reg. No. 40,511
`JONES DAY
`North Point
`901 Lakeside Avenue
`Cleveland, Ohio 44114
`General Tel: (216) 586-3939
`Direct Tel: (216) 586-7747
`Fax: (216) 579-0212
`jvbiernacki@jonesday.com
`
`Attorneys for Jazz Pharmaceuticals, Inc.
`
`
`
`3
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`AMNEAL PHARMACEUTICALS LLC, PAR PHARMACEUTICAL, INC., and
`WOCKHARDT BIO AG
`
`Petitioners,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.
`
`Patent Owner
`
`________________
`
`Case IPR2015-005472
`Patent 7,765,107
`________________
`
`CERTIFICATE OF SERVICE
`
`
`
`
`
`
`2 Case IPR2015-01820 has been joined with this proceeding.
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certifies that PATENT
`
`OWNER’S REQUEST FOR ORAL ARGUMENT PURSUANT TO 37 C.F.R.
`
`§ 42.70 was served on March 18, 2016 by filing this document through the Patent
`
`Review Processing System, as well as e-mailing a copy to mruedy@meiplaw.com,
`
`smaddox@meiplaw.com, and PCGallagher@duanemorris.com.
`
`
` Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito (Reg. No. 38,100)
` QUINN EMANUEL URQUHART &
` SULLIVAN, LLP
` 51 Madison Avenue, 22nd Floor
` New York, NY 10010
` General Tel: (212) 849-7000
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`
`Lead Counsel for
`Jazz Pharmaceuticals, Inc.
`
`
`
`
`Date: March 18, 2016